Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063156737> ?p ?o ?g. }
- W2063156737 endingPage "248" @default.
- W2063156737 startingPage "238" @default.
- W2063156737 abstract "Preclinical and clinical results indicate that the EGFR can mediate radioresistance in different solid human tumours. Combination of radiotherapy and EGFR inhibitors can improve local tumour control compared to irradiation alone and has been introduced into clinical radiotherapy practice. So far several mechanisms have been identified in preclinical studies to contribute to improved local tumour control after radiation combined with EGFR inhibitors. These include direct kill of cancer stem cells by EGFR inhibitors, cellular radiosensitization through modified signal transduction, inhibition of repair of DNA damage, reduced repopulation and improved reoxygenation during fractionated radiotherapy. Effects and mechanisms may differ for different classes of EGFR inhibitors, for different tumours and for normal tissues. The mechanisms underlying this heterogeneity are currently poorly understood, and predictive assays are not available yet. Importantly, mechanisms and predictors for the combined effects of radiation with EGFR inhibitors appear to be considerably different to those for application of EGFR inhibitors alone or in combination with chemotherapy. Therefore to further evaluate the efficacy and mechanisms of EGFR-inhibition in combined treatments, radiotherapy-specific preclinical research strategies, which include in vivo experiments using local tumour control as an endpoint, as well as animal studies on normal tissue toxicity are needed." @default.
- W2063156737 created "2016-06-24" @default.
- W2063156737 creator A5005417679 @default.
- W2063156737 creator A5012831415 @default.
- W2063156737 creator A5028492548 @default.
- W2063156737 creator A5053689153 @default.
- W2063156737 creator A5083101824 @default.
- W2063156737 creator A5084228761 @default.
- W2063156737 creator A5088659570 @default.
- W2063156737 date "2007-06-01" @default.
- W2063156737 modified "2023-10-01" @default.
- W2063156737 title "EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms" @default.
- W2063156737 cites W1481099429 @default.
- W2063156737 cites W1501383613 @default.
- W2063156737 cites W1964071325 @default.
- W2063156737 cites W1968366677 @default.
- W2063156737 cites W1970476748 @default.
- W2063156737 cites W1973376648 @default.
- W2063156737 cites W1974072028 @default.
- W2063156737 cites W1975767770 @default.
- W2063156737 cites W1977684281 @default.
- W2063156737 cites W1978856586 @default.
- W2063156737 cites W1978865306 @default.
- W2063156737 cites W1979583222 @default.
- W2063156737 cites W1980204784 @default.
- W2063156737 cites W1981329401 @default.
- W2063156737 cites W1983143162 @default.
- W2063156737 cites W1983648619 @default.
- W2063156737 cites W1985292397 @default.
- W2063156737 cites W1991618144 @default.
- W2063156737 cites W1992132675 @default.
- W2063156737 cites W1992514491 @default.
- W2063156737 cites W1992665293 @default.
- W2063156737 cites W1992676863 @default.
- W2063156737 cites W1992964845 @default.
- W2063156737 cites W1995870694 @default.
- W2063156737 cites W2001544973 @default.
- W2063156737 cites W2003984225 @default.
- W2063156737 cites W2007535198 @default.
- W2063156737 cites W2008046307 @default.
- W2063156737 cites W2008575388 @default.
- W2063156737 cites W2009570698 @default.
- W2063156737 cites W2014134684 @default.
- W2063156737 cites W2019443090 @default.
- W2063156737 cites W2022897735 @default.
- W2063156737 cites W2023427658 @default.
- W2063156737 cites W2025313715 @default.
- W2063156737 cites W2027557150 @default.
- W2063156737 cites W2029231546 @default.
- W2063156737 cites W2037395954 @default.
- W2063156737 cites W2039627804 @default.
- W2063156737 cites W2043696829 @default.
- W2063156737 cites W2046421136 @default.
- W2063156737 cites W2046675842 @default.
- W2063156737 cites W2047353118 @default.
- W2063156737 cites W2048454485 @default.
- W2063156737 cites W2049511709 @default.
- W2063156737 cites W2050587856 @default.
- W2063156737 cites W2051055358 @default.
- W2063156737 cites W2051266531 @default.
- W2063156737 cites W2062587088 @default.
- W2063156737 cites W2067471596 @default.
- W2063156737 cites W2072569544 @default.
- W2063156737 cites W2074094034 @default.
- W2063156737 cites W2074937243 @default.
- W2063156737 cites W2079957024 @default.
- W2063156737 cites W2083554413 @default.
- W2063156737 cites W2084518117 @default.
- W2063156737 cites W2085522693 @default.
- W2063156737 cites W2090871977 @default.
- W2063156737 cites W2093079481 @default.
- W2063156737 cites W2093207065 @default.
- W2063156737 cites W2094284800 @default.
- W2063156737 cites W2094337557 @default.
- W2063156737 cites W2096287391 @default.
- W2063156737 cites W2097702370 @default.
- W2063156737 cites W2102085111 @default.
- W2063156737 cites W2104905855 @default.
- W2063156737 cites W2106412408 @default.
- W2063156737 cites W2107304950 @default.
- W2063156737 cites W2109837588 @default.
- W2063156737 cites W2110835998 @default.
- W2063156737 cites W2112266802 @default.
- W2063156737 cites W2115416676 @default.
- W2063156737 cites W2118113452 @default.
- W2063156737 cites W2121389354 @default.
- W2063156737 cites W2122314043 @default.
- W2063156737 cites W2122885616 @default.
- W2063156737 cites W2122900223 @default.
- W2063156737 cites W2127101185 @default.
- W2063156737 cites W2130647939 @default.
- W2063156737 cites W2138297714 @default.
- W2063156737 cites W2138365635 @default.
- W2063156737 cites W2140775102 @default.
- W2063156737 cites W2142007209 @default.
- W2063156737 cites W2142564546 @default.
- W2063156737 cites W2142850084 @default.
- W2063156737 cites W2145478177 @default.